Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography

Tomás R. Guilarte, Jennifer L. McGlothan, Catherine A. Foss, Jia Zhou, Warren D. Heston, Alan P. Kozikowski, Martin G. Pomper

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The ability to visualize quantitatively glutamate carboxypeptidase II (GCPII) levels in vivo could advance our understanding of its function in health and disease. In the current study, we synthesized and evaluated a radiolabeled (iodine-125) analog of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-iodo-l- tyrosine (DCIT), a potent antagonist of GCPII activity. We examined the regional distribution of [125I]DCIT binding in the rodent brain using quantitative autoradiography in order to confirm the validity of this radioligand as a marker of GCPII in the brain. The ultimate goal is to develop an imaging agent for assessing GCPII levels in the living brain. The specific binding of [125I]DCIT to rat brain followed a regional distribution consistent with previous studies describing regional brain GCPII gene expression and activity. We found a modest rostrocaudal gradient in which specific binding of [125I]DCIT to GCPII was lowest in cortical regions, with increasing levels of binding in midbrain structures and high levels of binding in hindbrain and brainstem. Autoradiography of [125I]DCIT in GCPII knockout and wild type mouse brain showed a gene-dose dependency confirming the selectivity of this radioligand for GCPII. We propose that [125I]DCIT is a selective radioligand that can be used to quantify brain GCPII levels in vitro using quantitative autoradiography.

Original languageEnglish (US)
Pages (from-to)141-144
Number of pages4
JournalNeuroscience Letters
Volume387
Issue number3
DOIs
StatePublished - Oct 28 2005
Externally publishedYes

Fingerprint

Glutamate Carboxypeptidase II
Autoradiography
Rodentia
Brain
Rhombencephalon
Mesencephalon
Knockout Mice
Iodine
Brain Stem
Tyrosine

Keywords

  • Glutamate carboxypeptidase II (GCPII/NAALADase) levels
  • Quantitative autoradiography
  • Rodent brain

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Guilarte, T. R., McGlothan, J. L., Foss, C. A., Zhou, J., Heston, W. D., Kozikowski, A. P., & Pomper, M. G. (2005). Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography. Neuroscience Letters, 387(3), 141-144. https://doi.org/10.1016/j.neulet.2005.06.015

Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography. / Guilarte, Tomás R.; McGlothan, Jennifer L.; Foss, Catherine A.; Zhou, Jia; Heston, Warren D.; Kozikowski, Alan P.; Pomper, Martin G.

In: Neuroscience Letters, Vol. 387, No. 3, 28.10.2005, p. 141-144.

Research output: Contribution to journalArticle

Guilarte, TR, McGlothan, JL, Foss, CA, Zhou, J, Heston, WD, Kozikowski, AP & Pomper, MG 2005, 'Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography', Neuroscience Letters, vol. 387, no. 3, pp. 141-144. https://doi.org/10.1016/j.neulet.2005.06.015
Guilarte, Tomás R. ; McGlothan, Jennifer L. ; Foss, Catherine A. ; Zhou, Jia ; Heston, Warren D. ; Kozikowski, Alan P. ; Pomper, Martin G. / Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography. In: Neuroscience Letters. 2005 ; Vol. 387, No. 3. pp. 141-144.
@article{da62b96b9ce34436af1c0745447c95dd,
title = "Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography",
abstract = "The ability to visualize quantitatively glutamate carboxypeptidase II (GCPII) levels in vivo could advance our understanding of its function in health and disease. In the current study, we synthesized and evaluated a radiolabeled (iodine-125) analog of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-iodo-l- tyrosine (DCIT), a potent antagonist of GCPII activity. We examined the regional distribution of [125I]DCIT binding in the rodent brain using quantitative autoradiography in order to confirm the validity of this radioligand as a marker of GCPII in the brain. The ultimate goal is to develop an imaging agent for assessing GCPII levels in the living brain. The specific binding of [125I]DCIT to rat brain followed a regional distribution consistent with previous studies describing regional brain GCPII gene expression and activity. We found a modest rostrocaudal gradient in which specific binding of [125I]DCIT to GCPII was lowest in cortical regions, with increasing levels of binding in midbrain structures and high levels of binding in hindbrain and brainstem. Autoradiography of [125I]DCIT in GCPII knockout and wild type mouse brain showed a gene-dose dependency confirming the selectivity of this radioligand for GCPII. We propose that [125I]DCIT is a selective radioligand that can be used to quantify brain GCPII levels in vitro using quantitative autoradiography.",
keywords = "Glutamate carboxypeptidase II (GCPII/NAALADase) levels, Quantitative autoradiography, Rodent brain",
author = "Guilarte, {Tom{\'a}s R.} and McGlothan, {Jennifer L.} and Foss, {Catherine A.} and Jia Zhou and Heston, {Warren D.} and Kozikowski, {Alan P.} and Pomper, {Martin G.}",
year = "2005",
month = "10",
day = "28",
doi = "10.1016/j.neulet.2005.06.015",
language = "English (US)",
volume = "387",
pages = "141--144",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography

AU - Guilarte, Tomás R.

AU - McGlothan, Jennifer L.

AU - Foss, Catherine A.

AU - Zhou, Jia

AU - Heston, Warren D.

AU - Kozikowski, Alan P.

AU - Pomper, Martin G.

PY - 2005/10/28

Y1 - 2005/10/28

N2 - The ability to visualize quantitatively glutamate carboxypeptidase II (GCPII) levels in vivo could advance our understanding of its function in health and disease. In the current study, we synthesized and evaluated a radiolabeled (iodine-125) analog of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-iodo-l- tyrosine (DCIT), a potent antagonist of GCPII activity. We examined the regional distribution of [125I]DCIT binding in the rodent brain using quantitative autoradiography in order to confirm the validity of this radioligand as a marker of GCPII in the brain. The ultimate goal is to develop an imaging agent for assessing GCPII levels in the living brain. The specific binding of [125I]DCIT to rat brain followed a regional distribution consistent with previous studies describing regional brain GCPII gene expression and activity. We found a modest rostrocaudal gradient in which specific binding of [125I]DCIT to GCPII was lowest in cortical regions, with increasing levels of binding in midbrain structures and high levels of binding in hindbrain and brainstem. Autoradiography of [125I]DCIT in GCPII knockout and wild type mouse brain showed a gene-dose dependency confirming the selectivity of this radioligand for GCPII. We propose that [125I]DCIT is a selective radioligand that can be used to quantify brain GCPII levels in vitro using quantitative autoradiography.

AB - The ability to visualize quantitatively glutamate carboxypeptidase II (GCPII) levels in vivo could advance our understanding of its function in health and disease. In the current study, we synthesized and evaluated a radiolabeled (iodine-125) analog of N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-iodo-l- tyrosine (DCIT), a potent antagonist of GCPII activity. We examined the regional distribution of [125I]DCIT binding in the rodent brain using quantitative autoradiography in order to confirm the validity of this radioligand as a marker of GCPII in the brain. The ultimate goal is to develop an imaging agent for assessing GCPII levels in the living brain. The specific binding of [125I]DCIT to rat brain followed a regional distribution consistent with previous studies describing regional brain GCPII gene expression and activity. We found a modest rostrocaudal gradient in which specific binding of [125I]DCIT to GCPII was lowest in cortical regions, with increasing levels of binding in midbrain structures and high levels of binding in hindbrain and brainstem. Autoradiography of [125I]DCIT in GCPII knockout and wild type mouse brain showed a gene-dose dependency confirming the selectivity of this radioligand for GCPII. We propose that [125I]DCIT is a selective radioligand that can be used to quantify brain GCPII levels in vitro using quantitative autoradiography.

KW - Glutamate carboxypeptidase II (GCPII/NAALADase) levels

KW - Quantitative autoradiography

KW - Rodent brain

UR - http://www.scopus.com/inward/record.url?scp=23844507556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844507556&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2005.06.015

DO - 10.1016/j.neulet.2005.06.015

M3 - Article

C2 - 16006038

AN - SCOPUS:23844507556

VL - 387

SP - 141

EP - 144

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -